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tor salivary glands increased to 18 month and
next diminished to 60 months. For spinaJ cord
there was observed signiticant progression ot
intensity late toxicity (mild tunctional) during
second year after irradiation.
Conclusions:
1. SOMA-LENT scale seems to be adequate in
the clinical practice tor the estimation ot late
radiation toxicity ot H&N region tissues.
2. Ongoing study has preliminary nature and is
being continued.
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Introduction: Pulsed Dose Rate (POR)
treatment is a new brachytherapy modality that
combines·physical adventages ot high-dose-rate
(HDR) technology (isodose optimization,
radiation satety) with the radiobiological
adventages ot low-dose-rate (LOR)
brachytherapy.
Pulsed brachytherapy consists ot using a
stronger radiation source than tor LOR
brachytherapy and is giving a senes ot short
exposures ot 10 to 30 minutes in every hour to
approximately the same tataI dose in the same
overall as with the LOR. Modern afterloading
equipment offers some advantages over
intersitial or intracavitary insertion ot separate
needles, tubes, seeds or wires. Isodose
volumes in tissue can be created tlexibly by a
combination ot caretuJ placement ot the catheter
and adjustment ot the dwell times ot the
computerized stepping source. Automatic
removal ot the radiation sources into a shielded
sate eliminates radiation exposures to statt and
visitors. Radiation exposure is also eliminated to
the staff who tormerly loaded and unloaded a
multiplicity ot radioactive sources into the
catheters, ovoids, tubes etc.
Material and methods: This retrospective
study based on summarized clinical
investigations analyses the teasibility,
differences between methods ot brachytherapy
and preliminary oncologic results ot POR
brachytherapy.
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Since July 2000 15 patients were treated in
Greatpoland Cancer Center using POR
brachytherapy. They were 10 patients with
recurrent brain malignant glioma, 2 with
recurrent nasopharyngeal cancer, and patients
with lip cancer, recurrent breast cancer and
recurrent salivary gland cancer. Only patient
with lip cancer was treated radically. Nucietron
POR unit with 1 Ci source and PLATO planning
system were used.
Results: Short time ot observation doesn't
allow to draw a radical conclusions. On the
ground ot Iiterature and preliminary own results
it seems that POR brachytherapy is save and
efficient method ot treatmenł. The most
important compJication was a local infection in
place of implanted catheter. In some cases (tor
example in patients with recurrent malignant
glioma after teletherapy) POR brachytherapy
perhaps could be a treatment ot choice.
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Background: Repopulation during radiation
therapy may compromise the results ot the
treatment ot NSCLC. In spite ot the data
showing an improvement ot therapeutic ratio
with shortening ot the total treatment time, there
is no univoque way ot doing ił. Current study
was conducted to compare two different
regimens ot accelerated radiotherapy.
Material/Methods: From March 1999 to
November 2000 torty patients with stage III
NSCLC were included. Twenty-eight pts. (70%)
received 3-4 cycles ot induction chemotherapy
(cis-platinum, vepeside). Twenty-six p. were
treated according to RAHIP schema, 14 pts.
according to RT-BOOST schedule. RAHIP
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